Publication | Closed Access
Molecular characterization of COVID-19 therapeutics: luteolin as an allosteric modulator of the spike protein of SARS-CoV-2
14
Citations
22
References
2021
Year
Viral ReplicationViral PathogenesisImmunologyAntiviral DrugViral Structural ProteinCovid-19Spike ProteinSubsequent ReplicationAntiviral Drug DevelopmentAllosteric ModulatorVirologyPharmacologyAngiotensin-converting Enzyme 2Antiviral TherapyVirus-host InteractionViral EntrySystems BiologyMedicineCovid-19 Therapeutics
The interactions between the receptor binding domain (RBD) of SARS-CoV-2 and the angiotensin-converting enzyme 2 (ACE2) are crucial for viral entry and subsequent replication.
| Year | Citations | |
|---|---|---|
2009 | 23.9K | |
2020 | 23.1K | |
2020 | 21.1K | |
2020 | 9.7K | |
2013 | 7.3K | |
2020 | 5.5K | |
2012 | 4.3K | |
1993 | 3.4K | |
2020 | 3.2K | |
2012 | 2.6K |
Page 1
Page 1